Basic Information
Basic information for PART1-207-94aa
Peptide Name PART1-207-94aa
Genome Position chr5:60489859-60490140[+]
Species Human
Peptide Sequence MFKSPFVDRQSQQYSKLRPASHFICIFVQKFPIGRLHLLQLRRKPLLSKTVTSNHPQSFKWKLSQLLYILCVNIQLSYRLSPGSLTLTNTKSFV
Peptide Length 94
Unique No (PART1-203-94aa)
Grand Average of Hydropathicity -0.0989
Relative Molecular Mass 12670.55
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000152931;PART1
Transcript ID/Name ENST00000667192;PART1-207
Transcript Length 2831
Coding Ability 0.4214
DNA Sequence Corresponding to Peptide ATGTTCAAATCTCCATTTGTTGACAGACAAAGCCAACAATACTCTAAACTGAGGCCTGCAAGTCATTTCATTTGTATTTTTGTCCAGAAATTTCCCATAGGAAGACTTCACCTCCTACAACTCCGAAGAAAACCCTTACTGTCCAAGACCGTCACCAGCAACCATCCGCAGTCATTCAAGTGGAAGCTTTCACAGCTTTTGTACATTCTCTGTGTCAATATACAACTGAGTTACAGACTGTCCCCTGGCTCCCTGACCCTTACAAACACTAAAAGTTTTGTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :